Antibody-Drug Conjugate Tackles Glucocorticoid Use in PMR

A novel conjugate of adalimumab and a proprietary glucocorticoid receptor modulator for patients with PMR led to longer time to flare and fewer flares and reduced the glucocorticoid dose needed.
Medscape Medical News

source https://www.medscape.com/viewarticle/antibody-drug-conjugate-tackles-glucocorticoid-use-2025a10002ok?src=rss

Comments

Popular posts from this blog

RA and RA-ILD Linked to Higher Lung Cancer Risk

DC’s Harllee Harper Is Using Public Health Tools to Prevent Gun Violence. Will It Work?